FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4408511000001106: Prostin E2 3mg vaginal tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18038101000001118 Prostin E2 3mg vaginal tablets (Pfizer Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
18038201000001113 Prostin E2 3mg vaginal tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Is a Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet true Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has active ingredient Alprostadil false Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has active ingredient Posterior pituitary hormone false Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has active ingredient Dinoprostone false Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has manufactured dose form Pessary false Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Is a Prostin E2 true Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has specific active ingredient Dinoprostone true Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has dispensed dose form Pessary true Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has manufactured dose form Conventional release vaginal tablet true Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Prostin E2 3mg vaginal tablets (Pfizer Ltd) 8 pessary Is pack of False Prostin E2 3mg vaginal tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) 8 pessary Has AMP True Prostin E2 3mg vaginal tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start